{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:29:39Z","timestamp":1780349379555,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The LuMind IDSC Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As life expectancy of people with Down syndrome (DS) increases, so does the risk of Alzheimer\u2019s disease (AD). Identifying symptoms and tracking disease progression is especially challenging whenever levels of function vary before the onset of dementia. Goal Attainment Scaling (GAS), an individualized patient-reported outcome, can aid in monitoring disease progression and treatment effectiveness in adults with DS. Here, with clinical input, a validated dementia symptom menu was revised to facilitate GAS in adults living with Down Syndrome-associated Alzheimer\u2019s disease (DS-AD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Four clinicians with expertise in DS-AD and ten caregivers of adults living with DS-AD participated in semi-structured interviews to review the menu. Each participant reviewed 9\u201315 goal areas to assess their clarity and comprehensiveness. Responses were systematically and independently coded by two researchers as \u2018clear\u2019, \u2018modify\u2019, \u2018remove\u2019 or \u2018new\u2019. Caregivers were encouraged to suggest additional items and recommend changes to clarify items.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median caregiver age was 65\u2009years (range 54\u201377). Most were female (9\/10) with \u226515\u2009years of education (10\/10). Adults with DS-AD had a median age of 58\u2009years (range 52\u201361) and either a formal diagnosis (6\/10) or clinical suspicion (4\/10) of dementia. The initial symptom menu consisted of 67 symptoms each with 2\u201312 descriptors (589 total). The clinicians\u2019 adaptation yielded 58 symptoms each with 4\u201317 descriptors (580 total). Of these 580 descriptors, caregivers identified 37 (6%) as unclear; these were reworded, and one goal area (4 descriptors) was removed. A further 47 descriptors and one goal area were added to include caregiver-identified concepts. The final menu contained 58 goal areas, each with 7\u201317 descriptors (623 total).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A comprehensive symptom menu for adults living with DS-AD was developed to facilitate GAS. Incorporating expert clinician opinion and input from caregivers of adults with DS-AD identified meaningful items that incorporate patient\/caregiver perspectives.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-020-00278-7","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T13:28:51Z","timestamp":1610371731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of a symptom menu to facilitate Goal Attainment Scaling in adults with Down syndrome-associated Alzheimer\u2019s disease: a qualitative study to identify meaningful symptoms"],"prefix":"10.1186","volume":"5","author":[{"given":"Kari","family":"Knox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hampus","family":"Hillerstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Chicoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Lott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-995X","authenticated-orcid":false,"given":"Kenneth","family":"Rockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"278_CR1","volume-title":"People living with down syndrome in the USA: Births and population","author":"G de Graaf","year":"2019","unstructured":"de Graaf, G., Buckley, F., & Skotko, B. (2019). People living with down syndrome in the USA: Births and population Down syndrome education international https:\/\/suri.net\/us-population-factsheet 2019. Accessed 11 May 2020."},{"issue":"4","key":"278_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1533317518761093","volume":"33","author":"G Cipriani","year":"2018","unstructured":"Cipriani, G., Danti, S., Carlesi, C., & Di Fiorino, M. (2018). Aging with Down syndrome: The dual diagnosis: Alzheimer's disease and down syndrome. American Journal of Alzheimer's Disease and Other Dementias, 33(4), 253\u2013262. https:\/\/doi.org\/10.1177\/1533317518761093.","journal-title":"American Journal of Alzheimer's Disease and Other Dementias"},{"issue":"10","key":"278_CR3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2788.2006.00842.x","volume":"50","author":"A Coppus","year":"2006","unstructured":"Coppus, A., Evenhuis, H., Verberne, G.-J., et al. (2006). Dementia and mortality in persons with Down\u2019s syndrome. Journal of Intellectual Disability Research, 50(10), 768\u2013777. https:\/\/doi.org\/10.1111\/j.1365-2788.2006.00842.x.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"8","key":"278_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","volume":"46","author":"F Lai","year":"1989","unstructured":"Lai, F., & Williams, R. S. (1989). A prospective study of Alzheimer disease in Down syndrome. Archives of Neurology, 46(8), 849\u2013853. https:\/\/doi.org\/10.1001\/archneur.1989.00520440031017.","journal-title":"Archives of Neurology"},{"issue":"1","key":"278_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jir.12074","volume":"58","author":"M McCarron","year":"2014","unstructured":"McCarron, M., McCallion, P., Reilly, E., & Mulryan, N. (2014). A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome. Journal of Intellectual Disability Research, 58(1), 61\u201370. https:\/\/doi.org\/10.1111\/jir.12074.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"1","key":"278_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.trci.2018.10.006","volume":"4","author":"A Strydom","year":"2018","unstructured":"Strydom, A., Coppus, A., Blesa, R., et al. (2018). Alzheimer\u2019s disease in Down syndrome: An overlooked population for prevention trials. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions, 4(1), 703\u2013713. https:\/\/doi.org\/10.1016\/j.trci.2018.10.006.","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"issue":"3","key":"278_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1352\/1944-7558-122.3.247","volume":"122","author":"AJ Esbensen","year":"2017","unstructured":"Esbensen, A. J., Hooper, S. R., Fidler, D., et al. (2017). Outcome measures for clinical trials in Down syndrome. American Journal on Intellectual and Developmental Disabilities, 122(3), 247\u2013281. https:\/\/doi.org\/10.1352\/1944-7558-122.3.247.","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"issue":"1","key":"278_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11065-017-9341-9","volume":"27","author":"BA Lautarescu","year":"2017","unstructured":"Lautarescu, B. A., Holland, A. J., & Zaman, S. H. (2017). The early presentation of dementia in people with Down syndrome: A systematic review of longitudinal studies. Neuropsychology Review, 27(1), 31\u201345. https:\/\/doi.org\/10.1007\/s11065-017-9341-9.","journal-title":"Neuropsychology Review"},{"issue":"6","key":"278_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","volume":"15","author":"C Ballard","year":"2016","unstructured":"Ballard, C., Mobley, W., Hardy, J., Williams, G., & Corbett, A. (2016). Dementia in Down's syndrome. Lancet Neurology, 15(6), 622\u2013636. https:\/\/doi.org\/10.1016\/S1474-4422(16)00063-6.","journal-title":"Lancet Neurology"},{"issue":"6","key":"278_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","volume":"11","author":"D Hartley","year":"2015","unstructured":"Hartley, D., Blumenthal, T., Carrillo, M., et al. (2015). Down syndrome and Alzheimer\u2019s disease: Common pathways, common goals. Alzheimer's & Dementia, 11(6), 700\u2013709. https:\/\/doi.org\/10.1016\/j.jalz.2014.10.007.","journal-title":"Alzheimer's & Dementia"},{"key":"278_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott, I. T., & Head, E. (2019). Dementia in Down syndrome: Unique insights for Alzheimer\u2019s disease research. Nature Reviews. Neurology, 15, 135\u2013147.","journal-title":"Nature Reviews. Neurology"},{"issue":"5","key":"278_CR12","doi-asserted-by":"publisher","first-page":"e0154596","DOI":"10.1371\/journal.pone.0154596","volume":"11","author":"CM Startin","year":"2016","unstructured":"Startin, C. M., Rodger, E., Fodor-Wynne, L., Hamburg, S., & Strydom, A. (2016). Developing an informant questionnaire for cognitive abilities in Down syndrome: The cognitive scale for Down syndrome (CS-DS). PLoS One, 11(5), e0154596Published 2016 May 6. https:\/\/doi.org\/10.1371\/journal.pone.0154596.","journal-title":"PLoS One"},{"issue":"5","key":"278_CR13","doi-asserted-by":"publisher","first-page":"e0153917","DOI":"10.1371\/journal.pone.0153917","volume":"11","author":"A Sinai","year":"2016","unstructured":"Sinai, A., Hassiotis, A., Rantell, K., & Strydom, A. (2016). Assessing specific cognitive deficits associated with dementia in older adults with Down syndrome: Use and validity of the Arizona cognitive test battery (ACTB). PLoS One, 11(5), e0153917Published 2016 May 12. https:\/\/doi.org\/10.1371\/journal.pone.0153917.","journal-title":"PLoS One"},{"issue":"7","key":"278_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jir.12500","volume":"62","author":"M McCarron","year":"2018","unstructured":"McCarron, M., McCallion, P., Coppus, A., et al. (2018). Supporting advanced dementia in people with Down syndrome and other intellectual disability: Consensus statement of the international summit on intellectual disability and dementia. Journal of Intellectual Disability Research, 62(7), 617\u2013624. https:\/\/doi.org\/10.1111\/jir.12500.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"11","key":"278_CR15","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1002\/ajmg.a.38416","volume":"173","author":"LA Keeling","year":"2017","unstructured":"Keeling, L. A., Spiridigliozzi, G. A., Hart, S. J., Baker, J. A., Jones, H. N., & Kishnani, P. S. (2017). Challenges in measuring the effects of pharmacological interventions on cognitive and adaptive functioning in individuals with Down syndrome: A systematic review. American Journal of Medical Genetics. Part A, 173(11), 3058\u20133066. https:\/\/doi.org\/10.1002\/ajmg.a.38416.","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"6","key":"278_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF01530764","volume":"4","author":"TJ Kiresuk","year":"1968","unstructured":"Kiresuk, T. J., & Sherman, R. E. (1968). Goal attainment scaling: A general method for evaluating comprehensive community mental health programs. Community Mental Health Journal, 4(6), 443\u2013453. https:\/\/doi.org\/10.1007\/BF01530764.","journal-title":"Community Mental Health Journal"},{"issue":"5","key":"278_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jnnp.73.5.500","volume":"73","author":"K Rockwood","year":"2002","unstructured":"Rockwood, K., Graham, J. E., Fay, S., & ACADIE Investigators (2002). Goal setting and attainment in Alzheimer\u2019s disease patients treated with donepezil. Journal of Neurology, Neurosurgery, and Psychiatry, 73(5), 500\u2013507. https:\/\/doi.org\/10.1136\/jnnp.73.5.500.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"278_CR18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1503\/cmaj.051432","volume":"174","author":"K Rockwood","year":"2006","unstructured":"Rockwood, K., Fay, S., MacKnight, C., Gorman, M., & Video-Imaging Synthesis of Treating Alzheimer\u2019s Disease (VISTA) Investigators (2006). Attainment of treatment goals by people with Alzheimer\u2019s disease receiving galantamine: A randomized controlled trial. Canadian Medical Association Journal, 174(8), 1099\u20131105. https:\/\/doi.org\/10.1503\/cmaj.051432.","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"278_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/clpt.2010.68","volume":"88","author":"K Rockwood","year":"2010","unstructured":"Rockwood, K. (2010). An individualized approach to tracking and treating Alzheimer\u2019s disease. Clinical Pharmacology and Therapeutics, 88(4), 446\u2013449. https:\/\/doi.org\/10.1038\/clpt.2010.68.","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"278_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1532-5415.1992.tb02105.x","volume":"40","author":"P Stolee","year":"1992","unstructured":"Stolee, P., Rockwood, K., Fox, R. A., & Streiner, D. L. (1992). The use of goal attainment scaling in a geriatric care setting. Journal of the American Geriatrics Society, 40(6), 574\u2013578.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"1","key":"278_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00002060-199402000-00003","volume":"73","author":"BM Joyce","year":"1994","unstructured":"Joyce, B. M., Rockwood, K., & Mate-Kole, C. C. (1994). Use of goal attainment scaling in brain injury in a rehabilitation hospital. American Journal of Physical Medicine & Rehabilitation, 73(1), 10.","journal-title":"American Journal of Physical Medicine & Rehabilitation"},{"issue":"3","key":"278_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ageing\/28.3.275","volume":"28","author":"J Gordon","year":"1999","unstructured":"Gordon, J., Powell, C., & Rockwood, K. (1999). Goal attainment scaling as a measure of clinically important change in nursing-home patients. Age and Ageing, 28(3), 275\u2013281. https:\/\/doi.org\/10.1093\/ageing\/28.3.275.","journal-title":"Age and Ageing"},{"issue":"1","key":"278_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2318-7-16","volume":"7","author":"M Kloseck","year":"2007","unstructured":"Kloseck, M. (2007). The use of goal attainment scaling in a community health promotion initiative with seniors. BMC Geriatrics, 7(1), 16. https:\/\/doi.org\/10.1186\/1471-2318-7-16.","journal-title":"BMC Geriatrics"},{"issue":"1","key":"278_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apmr.2006.10.017","volume":"88","author":"M Wallen","year":"2007","unstructured":"Wallen, M., O\u2019Flaherty, S. J., & Waugh, M.-C. A. (2007). Functional outcomes of intramuscular Botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation, 88(1), 1\u201310. https:\/\/doi.org\/10.1016\/j.apmr.2006.10.017.","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"3","key":"278_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/153331759701200303","volume":"12","author":"D Hartman","year":"1997","unstructured":"Hartman, D., Borrie, M. J., Davison, E., & Stolee, P. (1997). Use of goal attainment scaling in a dementia special care unit. American Journal of Alzheimer's Disease, 12(3), 111\u2013116. https:\/\/doi.org\/10.1177\/153331759701200303.","journal-title":"American Journal of Alzheimer's Disease"},{"issue":"4","key":"278_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.apmr.2007.09.049","volume":"89","author":"F Khan","year":"2008","unstructured":"Khan, F., Pallant, J. F., & Turner-Stokes, L. (2008). Use of goal attainment scaling in inpatient rehabilitation for persons with multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 89(4), 652\u2013659. https:\/\/doi.org\/10.1016\/j.apmr.2007.09.049.","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"5","key":"278_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1533317518769475","volume":"33","author":"G Wilz","year":"2018","unstructured":"Wilz, G., Weise, L., Reiter, C., Reder, M., Machmer, A., & Soellner, R. (2018). Intervention helps family caregivers of people with dementia attain own therapy goals. American Journal of Alzheimer's Disease and Other Dementias, 33(5), 301\u2013308. https:\/\/doi.org\/10.1177\/1533317518769475.","journal-title":"American Journal of Alzheimer's Disease and Other Dementias"},{"issue":"11","key":"278_CR28","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/jgs.15541","volume":"66","author":"LA Jennings","year":"2016","unstructured":"Jennings, L. A., Ramirez, K. D., Hays, R. D., Wenger, N. S., & Reuben, D. B. (2016). Personalized goal attainment in dementia care: Measuring what persons with dementia and their caregivers want. Journal of the American Geriatrics Society, 66(11), 2120\u20132127. https:\/\/doi.org\/10.1111\/jgs.15541.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"12","key":"278_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/gerona\/54.12.M641","volume":"54","author":"P Stolee","year":"1999","unstructured":"Stolee, P., Stadnyk, K., Myers, A. M., & Rockwood, K. (1999). An individualized approach to outcome measurement in geriatric rehabilitation. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 54(12), 641\u2013647. https:\/\/doi.org\/10.1093\/gerona\/54.12.M641.","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"4","key":"278_CR30","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1111\/hae.13454","volume":"24","author":"JC Roberts","year":"2018","unstructured":"Roberts, J. C., Lattimore, S., Recht, M., et al. (2018). Goal attainment scaling for haemophilia (GAS-H\u0113m): Testing the feasibility of a new patient-centric outcome measure in people with haemophilia. Haemophilia., 24(4), e199\u2013e206. https:\/\/doi.org\/10.1111\/hae.13454.","journal-title":"Haemophilia."},{"issue":"1","key":"278_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40814-018-0377-2","volume":"4","author":"D Javadi","year":"2018","unstructured":"Javadi, D., Lamarche, L., Avilla, E., et al. (2018). Feasibility study of goal setting discussions between older adults and volunteers facilitated by an eHealth application: Development of the health TAPESTRY approach. Pilot and Feasibility Studies, 4(1), 184. https:\/\/doi.org\/10.1186\/s40814-018-0377-2.","journal-title":"Pilot and Feasibility Studies"},{"issue":"3","key":"278_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/14038196.2010.486040","volume":"12","author":"LA Hale","year":"2010","unstructured":"Hale, L. A. (2010). Using goal attainment scaling in physiotherapeutic home-based stroke rehabilitation. Advances in Physiotherapy, 12(3), 142\u2013149. https:\/\/doi.org\/10.3109\/14038196.2010.486040.","journal-title":"Advances in Physiotherapy"},{"issue":"20","key":"278_CR33","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3109\/09638288.2012.660600","volume":"34","author":"P Stolee","year":"2012","unstructured":"Stolee, P., Awad, M., Byrne, K., DeForge, R., Clements, S., & Glenny, C. (2012). A multi-site study of the feasibility and clinical utility of goal attainment scaling in geriatric day hospitals. Disability and Rehabilitation, 34(20), 1716\u20131726. https:\/\/doi.org\/10.3109\/09638288.2012.660600.","journal-title":"Disability and Rehabilitation"},{"issue":"4","key":"278_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2214.2008.00841.x","volume":"34","author":"D Steenbeek","year":"2008","unstructured":"Steenbeek, D., Ketelaar, M., Galama, K., & Gorter, J. W. (2008). Goal attainment scaling in paediatric rehabilitation: A report on the clinical training of an interdisciplinary team. Child: Care, Health and Development, 34(4), 521\u2013529. https:\/\/doi.org\/10.1111\/j.1365-2214.2008.00841.x.","journal-title":"Child: Care, Health and Development"},{"issue":"3","key":"278_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1369-7625.2009.00536.x","volume":"12","author":"JL Milne","year":"2009","unstructured":"Milne, J. L., Robert, M., Tang, S., Drummond, N., & Ross, S. (2009). Goal achievement as a patient-generated outcome measure for stress urinary incontinence. Health Expectations, 12(3), 288\u2013300. https:\/\/doi.org\/10.1111\/j.1369-7625.2009.00536.x.","journal-title":"Health Expectations"},{"issue":"2","key":"278_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/J006v19n02_03","volume":"19","author":"GA King","year":"1999","unstructured":"King, G. A., McDougall, J., Palisano, R. J., Gritzan, J., & Tucker, M. A. (1999). Goal attainment scaling: Its use in evaluating pediatric therapy programs. Physical & Occupational Therapy in Pediatrics, 19(2), 31\u201352. https:\/\/doi.org\/10.1080\/J006v19n02_03.","journal-title":"Physical & Occupational Therapy in Pediatrics"},{"issue":"3","key":"278_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/08946566.2018.1454864","volume":"30","author":"D Burnes","year":"2018","unstructured":"Burnes, D., Connolly, M.-T., Hamilton, R., & Lachs, M. S. (2018). The feasibility of goal attainment scaling to measure case resolution in elder abuse and neglect adult protective services intervention. Journal of Elder Abuse & Neglect, 30(3), 209\u2013222. https:\/\/doi.org\/10.1080\/08946566.2018.1454864.","journal-title":"Journal of Elder Abuse & Neglect"},{"issue":"6","key":"278_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/geront\/38.6.735","volume":"38","author":"AM Yip","year":"1998","unstructured":"Yip, A. M., Gorman, M. C., Stadnyk, K., Mills, W. G. M., MacPherson, M., & Rockwood, K. (1998). A standardized menu for goal attainment scaling in the care of frail elders. The Gerontologist, 38(6), 735\u2013742. https:\/\/doi.org\/10.1093\/geront\/38.6.735.","journal-title":"The Gerontologist"},{"issue":"6","key":"278_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1017\/S1041610216002180","volume":"29","author":"E Reeve","year":"2017","unstructured":"Reeve, E., Molin, P., Hui, A., & Rockwood, K. (2017). Exploration of verbal repetition in people with dementia using an online symptom-tracking tool. International Psychogeriatrics, 29(6), 959\u2013966. https:\/\/doi.org\/10.1017\/S1041610216002180.","journal-title":"International Psychogeriatrics"},{"issue":"6","key":"278_CR40","doi-asserted-by":"publisher","DOI":"10.2196\/13360","volume":"21","author":"K Rockwood","year":"2019","unstructured":"Rockwood, K., Sanon Aigbogun, M., Stanley, J., et al. (2019). The symptoms targeted for monitoring in a web-based tracking tool by caregivers of people with dementia and agitation: Cross-sectional study. Journal of Medical Internet Research, 21(6), e13360. https:\/\/doi.org\/10.2196\/13360.","journal-title":"Journal of Medical Internet Research"},{"issue":"4","key":"278_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1017\/S0317167100014670","volume":"40","author":"K Rockwood","year":"2013","unstructured":"Rockwood, K., Mitnitski, A., Black, S. E., Richard, M., & Defoy, I. (2013). Cognitive change in donepezil treated patients with vascular or mixed dementia. Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques, 40(4), 564\u2013571. https:\/\/doi.org\/10.1017\/S0317167100014670.","journal-title":"Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"},{"issue":"10","key":"278_CR42","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.jalz.2017.02.005","volume":"13","author":"K Rockwood","year":"2017","unstructured":"Rockwood, K., Howlett, S. E., Hoffman, D., Schindler, R., & Mitnitski, A. (2017). Clinical meaningfulness of Alzheimer's disease assessment scale-cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors. Alzheimers Dement, 13(10), 1098\u20131106. https:\/\/doi.org\/10.1016\/j.jalz.2017.02.005.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"278_CR43","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.2196\/jmir.1941","volume":"14","author":"K Rockwood","year":"2012","unstructured":"Rockwood, K., Zeng, A., Leibman, C., Mucha, L., & Mitnitski, A. (2012). Validation of an informant-reported web-based data collection to assess dementia symptoms. Journal of Medical Internet Research, 14(2), e42Published 2012 Mar 12. https:\/\/doi.org\/10.2196\/jmir.1941.","journal-title":"Journal of Medical Internet Research"},{"issue":"8","key":"278_CR44","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick, D. L., Burke, L. B., Gwaltney, C. J., et al. (2011). Content validity\u2014Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1\u2014 Eliciting concepts for a new PRO instrument. Value in Health, 14(8), 967\u2013977.","journal-title":"Value in Health"},{"issue":"8","key":"278_CR45","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick, D. L., Burke, L. B., Gwaltney, C. J., et al. (2011). Content validity\u2014Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 2\u2014Assessing respondent understanding. Value in Health, 14(8), 978\u2013988.","journal-title":"Value in Health"},{"issue":"2","key":"278_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1212\/wnl.53.2.331","volume":"53","author":"F Lai","year":"1999","unstructured":"Lai, F., Kammann, E., Rebeck, G. W., Anderson, A., Chen, Y., & Nixon, R. A. (1999). APOE genotype and gender effects on Alzheimer\u2019s disease in 100 adults with Down syndrome. Neurology., 53(2), 331\u2013336. https:\/\/doi.org\/10.1212\/wnl.53.2.331.","journal-title":"Neurology."},{"key":"278_CR47","doi-asserted-by":"publisher","first-page":"205031211882292","DOI":"10.1177\/2050312118822927","volume":"7","author":"Y Chun Tie","year":"2019","unstructured":"Chun Tie, Y., Birks, M., & Francis, K. (2019). Grounded theory research: A design framework for novice researchers. SAGE Open Medicine, 7, 2050312118822927. https:\/\/doi.org\/10.1177\/2050312118822927.","journal-title":"SAGE Open Medicine"},{"key":"278_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013). Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology, 13, 1\u20138.","journal-title":"BMC Medical Research Methodology"},{"key":"278_CR49","volume-title":"Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims","author":"US Food and Drug Administration","year":"2009","unstructured":"US Food and Drug Administration (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims https:\/\/www.fda.gov\/media\/77832\/download. Accessed 9 Apr 2020."},{"key":"278_CR50","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/gps.4606","volume":"32","author":"JB Blok","year":"2017","unstructured":"Blok, J. B., Scheirs, J. G. M., & Thijm, N. S. (2017). Personality and behavioural changes do not precede memory problems as possible signs of dementia in ageing people with Down syndrome. International Journal of Geriatric Psychiatry, 32, 1257\u20131263.","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"278_CR51","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1365-2788.2007.00956.x","volume":"51","author":"S Deb","year":"2007","unstructured":"Deb, S., Hare, M., & Prior, L. (2007). Symptoms of dementia among adults with Down\u2019s syndrome: A qualitative study. Journal of Intellectual Disability Research, 51, 726\u2013739.","journal-title":"Journal of Intellectual Disability Research"},{"key":"278_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neubiorev.2017.02.021","volume":"83","author":"M El Haj","year":"2017","unstructured":"El Haj, M., Roche, J., Jardri, R., Kapogiannis, D., Gallouj, K., & Antoine, P. (2017). Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease. Neuroscience and Biobehavioral Reviews, 83, 713\u2013720.","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"11","key":"278_CR53","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1017\/S104161021800220X","volume":"31","author":"L McGarrigle","year":"2019","unstructured":"McGarrigle, L., Howlett, S. E., Wong, H., Stanley, J., & Rockwood, K. (2019). Characterizing the symptom of misplacing objects in people with dementia: Findings from an online tracking tool. International Psychogeriatrics, 31(11), 1635\u20131641. https:\/\/doi.org\/10.1017\/S104161021800220X.","journal-title":"International Psychogeriatrics"},{"issue":"1","key":"278_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1741-1130.2004.04004.x","volume":"1","author":"WE Haley","year":"2004","unstructured":"Haley, W. E., & Perkins, E. A. (2004). Current status and future directions in family caregiving and aging people with intellectual disabilities. Journal of Policy and Practice in Intellectual Disabilities, 1(1), 24\u201330. https:\/\/doi.org\/10.1111\/j.1741-1130.2004.04004.x.","journal-title":"Journal of Policy and Practice in Intellectual Disabilities"},{"issue":"6","key":"278_CR55","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/gps.5283","volume":"35","author":"LM Fonseca","year":"2020","unstructured":"Fonseca, L. M., Padilla, C., Jones, E., et al. (2020). Amnestic and non-amnestic symptoms of dementia: An international study of Alzheimer's disease in people with Down's syndrome. International Journal of Geriatric Psychiatry, 35(6), 650\u2013661. https:\/\/doi.org\/10.1002\/gps.5283.","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"12","key":"278_CR56","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1212\/wnl.44.12.2315","volume":"44","author":"DS Knopman","year":"1994","unstructured":"Knopman, D. S., Knapp, M. J., Gracon, S. I., & Davis, C. S. (1994). The clinician interview-based impression (CIBI): A clinician's global change rating scale in Alzheimer's disease. Neurology., 44(12), 2315\u20132321. https:\/\/doi.org\/10.1212\/wnl.44.12.2315.","journal-title":"Neurology."},{"key":"278_CR57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/0269215508101742","volume":"23","author":"L Turner-Stokes","year":"2009","unstructured":"Turner-Stokes, L. (2009). Goal attainment scaling (GAS) in rehabilitation: A practical guide. Clinical Rehabilitation, 23, 362\u2013370. https:\/\/doi.org\/10.1177\/0269215508101742.","journal-title":"Clinical Rehabilitation"},{"issue":"8","key":"278_CR58","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.2196\/jmir.2461","volume":"15","author":"K Rockwood","year":"2013","unstructured":"Rockwood, K., Richard, M., Leibman, C., Mucha, L., & Mitnitski, A. (2013). Staging dementia from symptom profiles on a care partner website. Journal of Medical Internet Research, 15(8), e145Published 2013 Aug 7. https:\/\/doi.org\/10.2196\/jmir.2461.","journal-title":"Journal of Medical Internet Research"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-020-00278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41687-020-00278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-020-00278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T15:31:04Z","timestamp":1610379064000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-020-00278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1186\/s41687-020-00278-7","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"28 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was granted by WIRB-Copernicus Group Company IRB. The approval number is 20192259. All caregivers provided informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HH is President and CEO and JAH is CSO of the LuMind IDSC Foundation. This study was conducted by DGI Clinical Inc. in which KR is President, Chief Science Officer and a shareholder. KK, JS, TD, SS, SEH and TD are employees of DGI Clinical Inc. In the last 3\u2009years, KR has also attended an advisory board meeting for Roche\/Genentech and Nutricia and has given two talks sponsored by Nutricia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}